Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > How does Accelerated Approval work

<< Previous

Bullboard Posts

Next >>

Comment by CMHarring218431on Sep 11, 2024 9:15am

350 Views

Post# 36218254

RE:RE:RE:RE:RE:RE:How does Accelerated Approval work

Morning Noteable
I believe I have thanked you a few times for posting essential data relative to Oncy's success and the highlights of what is most poignant and your associated personal insight.
But why the constant repetition? Have you been hired as the in house promoter? Although, you confess to claiming that Oncy is a no brainer....are you silently just worried about your investment here? Perhaps, you realize what many here forget and think anyone and everyone needs reassurance while we languish here in frustration

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 21, 2024